The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016
05/25/2010

Ophthalmology Markets Like Glaucoma Face Generic Erosion While Macular Degeneration and Edema Experience Healthy Growth

Online PR News – 25-May-2010 – – GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis. However, the unmet need in the macular degeneration and macular edema markets make the ophthalmology market attractive despite generic erosion. The attractiveness of the macular degeneration and macular edema markets is evident from the considerable amount of research and development activity for these indications. The major factor driving the growth of the market is the rising awareness about the importance of detecting ophthalmic diseases early, the availability of effective diagnostic tools and an increase in the prevalence of diabetes. The expiry of blockbuster drugs’ patents and increasing pressure from cheap off-label products in some markets will be the key restraints for the market.

For more information please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=The-Future-of-Ophthalmology-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Strategies-to-Counter-Generic-Erosion-in-Key-Markets&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

The entry of generics will cause glaucoma’s market share to shrink. The macular degeneration and macular edema markets will eat into glaucoma’s share. The share of the market generated by allergic conjunctivitis therapies, which includes a considerable number of generics, will remain the same in 2016. Due to the extensive presence of generics in the market, allergic conjunctivitis companies will take steps to improve the revenue potential of their drugs. The Rx to OTC switch is one of the strategies that can be leveraged at the right time to increase revenue potential. In addition, strategies such as branded generics will be increasingly used in the ophthalmology market.

GBI Research finds the global ophthalmology market is facing changes such as low treatment seeking and diagnosis rates which will result in huge untapped opportunities in the market. This untapped market can be accessed by companies only if the treatment seeking and diagnosis rates for indications such as dy macular degeneration improve. Diagnosis is at times delayed despite effective tests available in the market. Encouraging early detection of ophthalmic diseases by increasing physician and patient awareness is important. The treatment usage pattern for 2009 suggests that approximately 123 million people did not seek treatment, were improperly diagnosed or lost to alternative care or other options during the course of treatment. The focus on a greater understanding of the disease and on early detection will help to improve the treatment seeking rate in the market. The ophthalmology market pipeline has a considerable number of products that focus on novel therapies. Some of the therapies are first-in-class and these will have the biggest impact on the market in the coming years. The market for dry macular degeneration and early stage glaucoma presents huge opportunities. Diabetic retinopathy also holds the potential for market expansion as many companies are interested in exploiting this market which has no approved products.

GBI Research’s report, “The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global ophthalmology therapeutics market. The report analyzes the ophthalmology markets in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive profiling for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

For more information please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=The-Future-of-Ophthalmology-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Strategies-to-Counter-Generic-Erosion-in-Key-Markets&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.gbiresearch.com